Over-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA III

Farouk, HishamMattarucco, Walter JavierBarriga, Rocio MartinaWang, Hao-ChienDiaz, Dina V.Khattab, AdelPacheco Gallego, ManuelAl Zaabi, AshrafPrice, David2023-11-302023-11-302022-12-01Farouk, H, Mattarucco, W J, Barriga, R M, Wang, H-C, Diaz, D V, Khattab, A, Pacheco Gallego, M, Al Zaabi, A & Price, D 2022, 'Over-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA III', European Respiratory Journal, vol. 60, no. Suppl. 66, 3434. https://doi.org/10.1183/13993003.congress-2022.34340903-1936RIS: urn:80DF47D653606F20312DA26F77612C48RIS: urn:80DF47D653606F20312DA26F77612C48https://hdl.handle.net/2164/22304207914engR MedicineROver-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA IIIJournal item10.1183/13993003.congress-2022.3434http://erj.ersjournals.com/content/60/suppl_66/3434.abstract60